7. Features Of Risk Factors For The Development Of Atherosclerosis-Associated Cardiovascular Diseases In The Kazakhstani Population. Ethnonational Aspect

Авторы

DOI:

https://doi.org/10.35805/BSK2025III007

Загрузки

Аннотация

Background. Atherosclerosis-associated cardiovascular diseases exhibit significant ethnic and regional variability in risk factors. Kazakhstan’s high cardiovascular disease mortality rates necessitate population-specific profiling, particularly given urban-rural disparities and lifestyle differences unique to Central Asia.

Methods. This cross-sectional study (2023–2024) analyzed 368 Kazakhstani adults stratified by European Atherosclerosis Society risk tiers: low (n=67), high (n=127), and very high risk (very high-risk group, n=174). Assessments included lipid profiles (low density lipoprotein, high density lipoprotein, and apolipoprotein B to apolipoprotein A ratio), lifestyle factors (smoking, diet, physical activity), and residence (urban/rural). Statistical analyses employed multiclass logistic regression (MNLogit) with FDR-adjusted p-values.

Results. Age (OR=8.01, 95% CI:4.40–14.58, p<0.001), male sex (OR=3.27, CI:1.82–5.88), and smoking (OR=7.19, CI:1.52–34.15) were strongly associated with very high-risk group. Rural residents faced 2.6-fold higher very high-risk group odds (CI:1.52–5.68, p=0.002) versus urban counterparts. Protective effects emerged for physical activity (OR=0.03, CI:0.004–0.32) and female sex (High-Density Lipoprotein: +8.1 mg/dL vs. males, p<0.001). No alcohol association was observed (p=0.836).

Conclusion. A thorough study of the gender aspect of the development of atherosclerotic pathology is required. Physical activity has a strong protective effect. It is interesting that, according to the comparative analysis of binary variables, rural residents have a higher risk of developing atherosclerosis.

Ключевые слова

atherosclerosis, cardiovascular risk factors, Kazakhstan, urban-rural disparities, lipid metabolism, preventive cardiology

Библиографические ссылки

  1. Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. Nov 7 2016;37(42):3232-3245. doi:10.1093/eurheartj/ehw334
  2. Timmis A, Townsend N, Gale C, et al. European Society of Cardiology: Cardiovascular Disease Statistics 2017. Eur Heart J. Feb 14 2018;39(7):508-579. doi:10.1093/eurheartj/ehx628
  3. Movsisyan NK, Vinciguerra M, Medina-Inojosa JR, Lopez-Jimenez F. Cardiovascular Diseases in Central and Eastern Europe: A Call for More Surveillance and Evidence-Based Health Promotion. Ann Glob Health. Feb 26 2020;86(1):21. doi:10.5334/aogh.2713
  4. Nonterah EA, Crowther NJ, Klipstein-Grobusch K, et al. Racial and Ethnic Differences in the Association Between Classical Cardiovascular Risk Factors and Common Carotid Intima-Media Thickness: An Individual Participant Data Meta-Analysis. J Am Heart Assoc. Aug 2 2022;11(15):e023704. doi:10.1161/JAHA.121.023704
  5. M FP. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Int J Behav Med. Jun 2017;24(3):321-419. doi:10.1007/s12529-016-9583-6
  6. Zhang M, Shi Y, Zhou B, et al. Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey. BMJ. Jan 11 2023;380:e071952. doi:10.1136/bmj-2022-071952
  7. Gupta R, Rao RS, Misra A, Sharma SK. Recent trends in epidemiology of dyslipidemias in India. Indian Heart J. May-Jun 2017;69(3):382-392. doi:10.1016/j.ihj.2017.02.020
  8. Mahmoud I, Sulaiman N. Prevalence of Metabolic Syndrome and Associated Risk Factors in the United Arab Emirates: A Cross-Sectional Population-Based Study. Front Public Health. 2021;9:811006. doi:10.3389/fpubh.2021.811006
  9. Lima TR, Silva DAS, Giehl MWC, D'Orsi E, Gonzalez-Chica DA. Clusters of Cardiometabolic Risk Factors and Their Association with Atherosclerosis and Chronic Inflammation among Adults and Elderly in Florianopolis, Southern Brazil. Arq Bras Cardiol. Jul 2021;117(1):39-48. doi:10.36660/abc.20200230
  10. Nakipov K, Omarova B, Kuandykova R, et al. Prevalence and risk factors of cardiovascular diseases among youths in Kazakhstan: a systematic review of the literature. Future Sci OA. Dec 2025;11(1):2526943. doi:10.1080/20565623.2025.2526943
  11. Kwasniewska M, Kostka T, Jegier A, et al. Regular physical activity and cardiovascular biomarkers in prevention of atherosclerosis in men: a 25-year prospective cohort study. BMC Cardiovasc Disord. Apr 5 2016;16:65. doi:10.1186/s12872-016-0239-x
  12. Whelton SP, Silverman MG, McEvoy JW, et al. Predictors of Long-Term Healthy Arterial Aging: Coronary Artery Calcium Nondevelopment in the MESA Study. JACC Cardiovasc Imaging. Dec 2015;8(12):1393-1400. doi:10.1016/j.jcmg.2015.06.019
  13. Gijsberts CM, Groenewegen KA, Hoefer IE, et al. Race/Ethnic Differences in the Associations of the Framingham Risk Factors with Carotid IMT and Cardiovascular Events. PLoS One. 2015;10(7):e0132321. doi:10.1371/journal.pone.0132321
  14. Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. Mar 7 2020;395(10226):795-808. doi:10.1016/S0140-6736(19)32008-2
  15. Chiva-Blanch G, Magraner E, Condines X, et al. Effects of alcohol and polyphenols from beer on atherosclerotic biomarkers in high cardiovascular risk men: a randomized feeding trial. Nutr Metab Cardiovasc Dis. Jan 2015;25(1):36-45. doi:10.1016/j.numecd.2014.07.008
  16. Regitz-Zagrosek V, Gebhard C. Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes. Nat Rev Cardiol. Apr 2023;20(4):236-247. doi:10.1038/s41569-022-00797-4
  17. Connelly PJ, Azizi Z, Alipour P, Delles C, Pilote L, Raparelli V. The Importance of Gender to Understand Sex Differences in Cardiovascular Disease. Can J Cardiol. May 2021;37(5):699-710. doi:10.1016/j.cjca.2021.02.005
  18. Aengevaeren VL, Mosterd A, Sharma S, et al. Exercise and Coronary Atherosclerosis: Observations, Explanations, Relevance, and Clinical Management. Circulation. Apr 21 2020;141(16):1338-1350. doi:10.1161/CIRCULATIONAHA.119.044467
  19. Imran TF, Patel Y, Ellison RC, et al. Walking and Calcified Atherosclerotic Plaque in the Coronary Arteries: The National Heart, Lung, and Blood Institute Family Heart Study. Arterioscler Thromb Vasc Biol. Jun 2016;36(6):1272-7. doi:10.1161/ATVBAHA.116.307284

Опубликован

2025-09-30

Выпуск

Раздел

Статьи